Child (Latest Articles)

Latest indexed articles for 'Child'

Articles 41 to 50 of 200:

Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129.

29 Nov 2009 BACKGROUND: This report focuses on the children enrolled on the first North American Intergroup study of APL (INT0129). This study was designed to compare the rates of CR, disease-free survival (DFS), overall survival (OS) and toxicity of therapy ...
rec_pub_19743516-treatment-children-acute-promyelocytic-leukemia-results-north.htm

Childhood and adolescent lymphoblastic lymphoma: end of the beginning and future directions.

29 Nov 2009
rec_pub_19672977-childhood-adolescent-lymphoblastic-lymphoma-end-beginning-future.htm

mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death.

29 Nov 2009 BACKGROUND: Increased activity of multidrug resistance (MDR) genes has been associated with treatment failure in acute leukemias, although with controversial reports. The objective of the present study was to assess the expression profile of the ...
rec_pub_19672972-mrna-expression-profile-multidrug-resistance-genes-childhood-acute.htm

Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.

29 Nov 2009 BACKGROUND: Kinsbourne syndrome or opsoclonus myoclonus syndrome (OMS) is characterized by rapid, involuntary, irregular conjugate eye movements (opsoclonus), myoclonic jerking of the limbs and trunk, ataxia, and behavioral disturbances. In general, ...
rec_pub_19672966-improvement-neurological-status-quality-life-children-opsoclonus.htm

Is immunization necessary after therapy for acute lymphoblastic leukemia (ALL) has been completed?

29 Nov 2009
rec_pub_19653293-is-immunization-necessary-therapy-acute-lymphoblastic-leukemia.htm

A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report.

29 Nov 2009 BACKGROUND: Despite the increasing cure rates for children with acute lymphoblastic leukemia (ALL), patients who relapse continue to have poor prognosis. The Children's Oncology Group (COG) conducted a limited institution Phase II trial of ...
rec_pub_19637330-a-phase-ii-study-campath-1h-children-relapsed-refractory-acute.htm

Thrombolysis for pediatric venous thromboembolism: is it time for a trial?

29 Nov 2009
rec_pub_19637329-thrombolysis-pediatric-venous-thromboembolism-time-trial.htm

Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.

29 Nov 2009 BACKGROUND: The prognosis for recurrent/progressive Ewing sarcoma (ES) remains poor. Pre-clinical, adult phase I and II trials have demonstrated the combination of irinotecan and temozolomide to have schedule-dependent synergy and significant ...
rec_pub_19637327-irinotecan-temozolomide-ewing-sarcoma-memorial-sloan-kettering.htm

Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor.

29 Nov 2009 BACKGROUND: Hepatoblastoma is a rare malignancy of childhood. The scarcity of adequate cell models has limited our understanding of this tumor. Here we describe and characterize a new human liver tumor cell line, Hep293TT, derived from an aggressive ...
rec_pub_19637320-establishment-characterization-cancer-cell-line-derived-aggressive.htm

Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma.

29 Nov 2009 BACKGROUND: Ewing sarcoma (ES) is the second most common solid bone and soft tissue malignancy in children and young adults with low cure rates indicating the need to identify further prognostic markers. The importance of methylation in the ...
rec_pub_19637319-aberrant-methylation-reduced-expression-rassf1a-ewing-sarcoma.htm

Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]